<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>CancerCompass Message Board: MSLT II Study</title>
    <description>CancerCompass message board discussion started by Mrs. c on 2/16/2007</description>
    <link>http://www.cancercompass.com/message-board/message/all,9675,0.htm</link>
    <pubDate>Sun, 07 Sep 2008 00:00:00 GMT</pubDate>
    <lastBuildDate>Sun, 07 Sep 2008 00:00:00 GMT</lastBuildDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title>MSLT II Study</title>
      <description>Has anyone heard of the MSLT II Study for LND surgery?&amp;nbsp; My son has proven eligible for this study that is in phase III.&amp;nbsp; It is to study the benefits vs. the risks/complications of LND - quality of life, intervals of NED and overall survival outcome.&amp;nbsp; One group gets the surgery, another does not and is monitered with ultrasound for mel cells.&amp;nbsp; I have never heard ultrasound even mentioned as a tool for dx. or monitering.&amp;nbsp; Just wondering&amp;nbsp; if anyone has any knowledge as we make this decision.Darlene</description>
      <author>Mrs. c</author>
      <pubDate>Fri, 16 Feb 2007 00:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>